Skip to main content

Table 1 Baseline demographics, presentations, tumor type, location, angiographic features, and management

From: Trans-arterial embolization of malignant tumor-related gastrointestinal bleeding: technical and clinical efficacy

Age (years) Mean ± SD

mean age 55.5 years (range 42 - 69 years)

Sex (M/F)

9/5

Presentation

➢ Hematemesis

11 (78.4%)

➢ Melena

7 (50%)

Tumor type

➢ Gastric Adenocarcinoma

8 (57.1%)

➢ Gastric lymphoma

3 (21.5%)

➢ GIST

2 (14.3%)

➢ Colonic adenocarcinoma

1 (7.1%)

Bleeding location

➢ Gastric

11 (78.5%)

➢ Small Intestinal

3 (21.5%)

Angiographic features:

➢ Tumor blush

12 (85.7%)

➢ Neovascularity

9 (64.3%)

➢ Extravasation

2 (14.3%)

Management:

➢ TAE with gelatin sponge particles.

2/14 (14.3%)

➢ TAE with gelatin sponge particles and repeated procedure with PVA.

3/14 (21.5%)

➢ TAE with PVA particles.

8/14 (57.1%)